Guihong Yang

2PUBLICATIONS
0CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 12, 2025
Translational Model-Informed Dose Selection for Iruplinalkib, a Selective Oral ALK/ROS1 Tyrosine Kinase Inhibitor.

Guihong Yang, Yimei Wang, Huimin Zhao

|Dec 27, 2024
Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors.

Guihong Yang, Yimei Wang, Huimin Zhao

Pageof 1

Frequent Collaborators